Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/37082
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BATEN, Evert | - |
dc.contributor.author | Van der Aa, F. | - |
dc.contributor.author | GOETHUYS, Hans | - |
dc.contributor.author | Slabbaert, K. | - |
dc.contributor.author | ARIJS, Ingrid | - |
dc.contributor.author | VAN RENTERGHEM, Koenraad | - |
dc.date.accessioned | 2022-03-30T09:16:16Z | - |
dc.date.available | 2022-03-30T09:16:16Z | - |
dc.date.issued | 2021 | - |
dc.date.submitted | 2022-03-25T10:26:48Z | - |
dc.identifier.citation | The Journal of urology, 205 (6) , p. 1748 -1752 | - |
dc.identifier.issn | 0022-5347 | - |
dc.identifier.issn | 1527-3792 | - |
dc.identifier.uri | http://hdl.handle.net/1942/37082 | - |
dc.description.abstract | Purpose: We sought to determine whether omitting antimicrobial prophylaxis is safe in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative catheter. Materials and Methods: We conducted a multicenter randomized controlled trial from September 17, 2017 until December 31, 2019 in 5 hospitals. Patients with pyuria (>100 white blood cells/ml) and a preoperative indwelling catheter were excluded. Postoperative fever was defined as a body temperature >= 38.3C. A noninferiority design was used with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (antimicrobial prophylaxis group) - E (no antimicrobial prophylaxis group) >=Delta (6% noninferiority margin). A multivariable, logistic regression was performed regarding posttransurethral resection of the prostate fever and antimicrobial prophylaxis with co-variates: (clot-)retention and operating time. The R Project (R) for statistical computing was used and a p value of 0.05 was considered as statistically significant. Results: Of the patients 474 were included for multivariable analysis and 211/ 474 (44.5%) received antimicrobial prophylaxis vs 263/474 (55.5%) patients without antimicrobial prophylaxis. Antibiotics were fluoroquinolones in 140/211 (66.4%), cephazolin in 58/211 (27.5%) and amikacin in 13/211 (6.2%) patients. Fever occurred in 9/211 (4.4%) patients with antimicrobial prophylaxis vs 13/263 (4.9%) without antimicrobial prophylaxis (p=0.8, risk difference 0.006 [95% CI -0.003-0.06, relative risk 1.16]). We were able to exclude a meaningful increase in harm associated with omitting antimicrobial prophylaxis (p=0.4; adjusted risk difference 0.016 [95% CI -0.02-0.05]). Conclusions: Our data demonstrate the safety of omitting antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative indwelling catheter. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.rights | 2021 by American Urological Association Education and Research, Inc. | - |
dc.subject.other | transurethral resection of prostate | - |
dc.subject.other | randomized controlled trial | - |
dc.subject.other | fever | - |
dc.subject.other | drug resistance | - |
dc.subject.other | microbialantibiotic prophylaxis | - |
dc.title | Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1752 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 1748 | - |
dc.identifier.volume | 205 | - |
local.format.pages | 5 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Baten, E (corresponding author), AZ Diest UHasselt, Associatie Urol Hageland RZ Tienen, Kapellekensweg 10, Kessel Lo, Belgium. | - |
dc.description.notes | Evert.baten@gmail.com | - |
local.publisher.place | TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1097/JU.0000000000001638 | - |
dc.identifier.pmid | 33560163 | - |
dc.identifier.isi | WOS:000760589000043 | - |
dc.identifier.eissn | 1527-3792 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Baten, E.; Slabbaert, K.] Associatie Urol Hageland, Tielt Winge, Belgium. | - |
local.description.affiliation | [Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Leuven, Belgium. | - |
local.description.affiliation | [Goethuys, H.] Ziekenhuis Oost Limburg, Genk, Belgium. | - |
local.description.affiliation | [Arijs, I; van Renterghem, K.] Ctr Canc Biol, Leuven, Belgium. | - |
local.description.affiliation | [Baten, E.; van Renterghem, K.] Univ Hasselt, Hasselt, Belgium. | - |
local.description.affiliation | [van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Hasselt, Belgium. | - |
local.uhasselt.international | no | - |
item.fulltext | No Fulltext | - |
item.contributor | BATEN, Evert | - |
item.contributor | Van der Aa, F. | - |
item.contributor | GOETHUYS, Hans | - |
item.contributor | Slabbaert, K. | - |
item.contributor | ARIJS, Ingrid | - |
item.contributor | VAN RENTERGHEM, Koenraad | - |
item.fullcitation | BATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbaert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial. In: The Journal of urology, 205 (6) , p. 1748 -1752. | - |
item.accessRights | Closed Access | - |
item.validation | ecoom 2023 | - |
crisitem.journal.issn | 0022-5347 | - |
crisitem.journal.eissn | 1527-3792 | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.